{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T10:28:35Z","timestamp":1791109715812,"version":"4.1.0"},"reference-count":16,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2006,1,17]],"date-time":"2006-01-17T00:00:00Z","timestamp":1137456000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2006,1,17]],"date-time":"2006-01-17T00:00:00Z","timestamp":1137456000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pharmacogenomics J"],"published-print":{"date-parts":[[2006,7,1]]},"DOI":"10.1038\/sj.tpj.6500356","type":"journal-article","created":{"date-parts":[[2006,1,17]],"date-time":"2006-01-17T08:30:40Z","timestamp":1137486640000},"page":"265-268","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":334,"title":["A marker for Stevens-Johnson syndrome \u2026: ethnicity matters"],"prefix":"10.1038","volume":"6","author":[{"given":"C","family":"Lonjou","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L","family":"Thomas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N","family":"Borot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N","family":"Ledger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C","family":"de Toma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H","family":"LeLouet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E","family":"Graf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M","family":"Schumacher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A","family":"Hovnanian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M","family":"Mockenhaupt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J-C","family":"Roujeau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"(for the RegiSCAR group)","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2006,1,17]]},"reference":[{"key":"BF6500356_CR1","doi-asserted-by":"publisher","first-page":"1600","DOI":"10.1056\/NEJM199512143332404","volume":"333","author":"JC Roujeau","year":"1995","unstructured":"Roujeau JC, Kelly JP, Naldi L, Rzany B, Stern RS, Anderson T et al. Medication use and risk of Stevens-Johnson syndrome or toxic epidermal necrolysis. New Engl J Med 1995; 333: 1600\u20131607.","journal-title":"New Engl J Med"},{"key":"BF6500356_CR2","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1097\/00002030-200109280-00014","volume":"15","author":"JP Fagot","year":"2001","unstructured":"Fagot JP, Mockenhaupt M, Bouwes-Bavinck JN, Naldi L, Viboud C, Roujeau J-C . Nevirapine and the risk of Stevens-Johnson syndrome or toxic epidermal necrolysis: preliminary results of a case-control study. AIDS 2001; 15: 1\u20136.","journal-title":"AIDS"},{"key":"BF6500356_CR3","doi-asserted-by":"publisher","first-page":"490","DOI":"10.1126\/science.282.5388.490","volume":"282","author":"I Viard","year":"1998","unstructured":"Viard I, Wehrli P, Bullani R, Schneider P, Holler N, Salomon D et al. Inhibition of toxic epidermal necrolysis by blockade of CD95 with human intravenous immunoglobin. Science 1998; 282: 490\u2013493.","journal-title":"Science"},{"key":"BF6500356_CR4","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1034\/j.1399-0004.1999.560401.x","volume":"56","author":"DW Nebert","year":"1999","unstructured":"Nebert DW . Pharmacogenetics and pharmacogenomics: why is this relevant to the clinical geneticist? Clin Genet 1999; 56: 247\u2013258.","journal-title":"Clin Genet"},{"key":"BF6500356_CR5","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1016\/S0140-6736(02)07873-X","volume":"359","author":"S Mallal","year":"2002","unstructured":"Mallal S, Nolan D, Witt C, Mosel G, Martin AM, Moore C et al. Association between presence of HLA-B*5701, HLA-DR7, and HLA-DQ3 and hypersensitivity to HIV1 reverse-transcriptase inhibitor abacavir. Lancet 2002; 359: 727\u2013732.","journal-title":"Lancet"},{"key":"BF6500356_CR6","doi-asserted-by":"publisher","first-page":"1121","DOI":"10.1016\/S0140-6736(02)08158-8","volume":"359","author":"S Hetherington","year":"2002","unstructured":"Hetherington S, Hughes AR, Mosteller M, Shortino D, Baker KL, Spreen W et al. Genetic variation in HLA-B region and hypersensitivity reactions to abacavir. Lancet 2002; 359: 1121\u20131122.","journal-title":"Lancet"},{"key":"BF6500356_CR7","doi-asserted-by":"publisher","first-page":"1209","DOI":"10.1016\/j.jaci.2004.07.047","volume":"114","author":"A Nassif","year":"2004","unstructured":"Nassif A, Bensussan A, Boumsell L, Deniaud A, Moslehi H, Wolkenstein P et al. Toxic epidermal necrolysis: effector cells are drug specific cytotoxic T cells. J Allergy Clin Immunol 2004; 114: 1209\u20131215.","journal-title":"J Allergy Clin Immunol"},{"key":"BF6500356_CR8","doi-asserted-by":"publisher","first-page":"1879","DOI":"10.1002\/eji.200323630","volume":"33","author":"H Azukizawa","year":"2003","unstructured":"Azukizawa H, Kasaka H, Sano S, Heath WR, Takahashi I, Gao X et al. Induction of T-Cell mediated skin disease specific for antigen transgenically expressed in keratinocytes. Eur J Immunol 2003; 33: 1879\u20131888.","journal-title":"Eur J Immunol"},{"key":"BF6500356_CR9","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1038\/428486a","volume":"428","author":"WH Chung","year":"2004","unstructured":"Chung WH, Hung SI, Hong HS, Hsih MS, Yang LC, Ho HC et al. A marker for Stevens-Johnson syndrome. Nature 2004; 428: 486.","journal-title":"Nature"},{"key":"BF6500356_CR10","doi-asserted-by":"publisher","first-page":"1171","DOI":"10.1001\/archderm.1987.01660330082014","volume":"123","author":"JC Roujeau","year":"1987","unstructured":"Roujeau JC, Huynh TN, Bracq C, Guillaume JC, Revuz J, Touraine R . Genetic susceptibility to toxic epidermal necrolysis. Arch Dermatol 1987; 123: 1171\u20131173.","journal-title":"Arch Dermatol"},{"key":"BF6500356_CR11","first-page":"327","volume-title":"HLA 1998","author":"L Geer","year":"1998","unstructured":"Geer L, Terasaki PI, Gjertson DJ . HLA frequency. HLA. In: Gjertson DW, Terasaki PI (eds). HLA 1998. Lenexa: American Society for Histrocompatibility and Immunogenetics: 1998, pp. 327\u2013363."},{"key":"BF6500356_CR12","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1016\/0092-8674(94)90336-0","volume":"76","author":"RN Germain","year":"1994","unstructured":"Germain RN . MHC-dependent antigen processing and peptide presentation: providing ligands for T lymphocyte activation. Cell 1994; 76: 287\u2013299.","journal-title":"Cell"},{"key":"BF6500356_CR13","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1146\/annurev.iy.13.040195.003103","volume":"13","author":"DR Madden","year":"1995","unstructured":"Madden DR . The three dimensional structure of peptide-MHC complexes. Ann Rev Immunol 1995; 13: 587\u2013622.","journal-title":"Ann Rev Immunol"},{"key":"BF6500356_CR14","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1007\/s002510050594","volume":"50","author":"A Sette","year":"1999","unstructured":"Sette A, Sidney J . Nine major HLA class I supertypes account for the vast preponderance of HLA-A and -B polymorphism. Immunogenetics 1999; 50: 201\u2013212.","journal-title":"Immunogenetics"},{"key":"BF6500356_CR15","doi-asserted-by":"publisher","first-page":"6647","DOI":"10.4049\/jimmunol.164.12.6647","volume":"164","author":"B Schnyder","year":"2000","unstructured":"Schnyder B, Burkhart C, Schnyder-Frutig K, von Greyerz S, Naisbitt DJ, Pirmohamed M et al. Recognition of sulfomethoxazole and its reactive metabolites by Drug-Specific CD4+ T cells from allergic Individuals. J Immunol 2000; 164: 6647\u20136654.","journal-title":"J Immunol"},{"key":"BF6500356_CR16","doi-asserted-by":"publisher","first-page":"4134","DOI":"10.1073\/pnas.0409500102","volume":"102","author":"SH Hung","year":"2005","unstructured":"Hung SH, Chung WH, Liou LB, Chu CC, Lin M, Huang HP et al. HLA-B*5801 allele as a genetic marker for severe cutaneous adverse reactions caused by allopurinol. Proc Natl Acad Sci USA 2005; 102: 4134\u20134139.","journal-title":"Proc Natl Acad Sci USA"}],"container-title":["The Pharmacogenomics Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/6500356.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/6500356","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/6500356.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,22]],"date-time":"2022-03-22T10:46:07Z","timestamp":1647945967000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/6500356"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,1,17]]},"references-count":16,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2006,7,1]]}},"alternative-id":["BF6500356"],"URL":"https:\/\/doi.org\/10.1038\/sj.tpj.6500356","relation":{},"ISSN":["1470-269X","1473-1150"],"issn-type":[{"value":"1470-269X","type":"print"},{"value":"1473-1150","type":"electronic"}],"subject":[],"published":{"date-parts":[[2006,1,17]]},"assertion":[{"value":"27 June 2005","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 October 2005","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 October 2005","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 January 2006","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}